Navigation Links
Mylan Reports That the FDA Determined That All Accusations Were Unfounded
Date:7/28/2009

PITTSBURGH, July 28 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today reported that in addition to the press release it issued on Sunday, the company proactively and as a courtesy had contacted the U.S. Food and Drug Administration (FDA) over the weekend to bring to its attention a recent news article. As a result, the FDA visited the company's Morgantown, W.Va., manufacturing facility Monday morning and has determined that the baseless accusations in the article were unfounded. The FDA noted there was no evidence of any data deletion. All data was reviewed and was present and accounted for; the Agency agreed that this was a minor Standard Operating Procedures (SOP) deviation that existed, was fully investigated, and all corrective actions were fully implemented by Mylan.

Mylan Chairman and CEO Robert J. Coury said: "I want to first thank the FDA for responding as quickly as it did in light of the seriousness of these unfounded accusations. I hope that these actions only reaffirm Mylan's long-standing reputation as one of the industry's highest quality manufacturers with a management team that has an unyielding commitment to adhere to the highest quality standards. I also want to thank all of the employees in Morgantown for their continued dedication, hard work and commitment to uphold one of the industry's highest quality standards. As far as the abnormal trading volume in our stock yesterday, the only thing I have to say is that there is no one in a better position to speak about these issues for a company than the standing fiduciaries, whether it is the senior management of the company or any regulatory agency. I would hope that the market and our stakeholders take note of this."

Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified g
'/>"/>

SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Mylan Reiterates and Stands Behind Its 48-Year Commitment and Track Record of Quality
2. Mylan Receives FDA Approval for Additional Strengths of the Antipsychotic Haloperidol
3. Mylan Declares Quarterly Preferred Stock Dividend
4. Mylan Receives FDA Approval for Generic Version of Thyroid Deficiency Treatment Cytomel(R)
5. Mylan Schedules Second Quarter 2009 Financial Results Conference Call and Live Webcast
6. Mylan Receives FDA Approval for Additional Strength of Generic Restoril(R)
7. Mylans Chief Operating Officer Heather Bresch to Testify Before Congress Concerning Patent Settlements Between Brand and Generic Pharmaceutical Companies and Tactics That Delay Market Entry of High Quality, Affordable Generic Drugs
8. Mylan Announces Successful Matrix Delisting Offer
9. Mylan Announces Change in Board Leadership
10. Mylan Receives Final FDA Approvals for Generic Versions of Anti-Rejection Medication CellCept(R)
11. Mylan Schedules First Quarter 2009 Financial Results Conference Call and Live Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2015)... As residents and business owners ... Burns and Carita Weaver, believe in supporting local ... the Southlake Chamber of Commerce, Carroll Independent School ... launched a website for Southlake mayoral candidate Laura ... tool for Hill’s campaign, the website combines images, ...
(Date:3/1/2015)... 2015 Adults who are not legally ... term or universal policies can now use the QuotesPros.com ... life insurance companies for single adults can now be ... http://quotespros.com/life-insurance.html . , The rate plans that nationwide agencies ... to a number of life protection policies. The term, ...
(Date:3/1/2015)... York, NY (PRWEB) March 01, 2015 ... has grown substantially over the past few weeks in ... LLP are actively filing claims, the Firm announces. ... reflects 7,713 cases in the Bergen County proceeding established ... Inc., compared with a few weeks earlier, when 90 ...
(Date:3/1/2015)... Theme and plugin developers from Pixel ... pack for Final Cut Pro X entitled Transccordion. , ... any FCPX editors project.” Said Christiana Austin, CEO of ... needed to easily drag and drop their accordion transition ... different controls over the parameters of this transition bundle ...
(Date:2/28/2015)... Dallas, TX (PRWEB) March 01, 2015 ... is estimated that 10 percent of urban adult population ... some form of heart diseases and 20-30 percent of ... due to heart ailments and coronary vascular diseases (CVD). ... has launched a new market research report titled “Indian ...
Breaking Medicine News(10 mins):Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 4Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3
... (OTCBB:PVCT) announced that it has obtained approval to begin Phase ... III and IV metastatic melanoma, the most aggressive and deadly ... evaluate efficacy of Provecta in a total of 80 subjects. ... into up to 20 tumors in each subject. Additional treatment ...
... 6 Nuvelo, Inc.,(Nasdaq: NUVO ) today ... in September: Bank of America 37th Annual ... PT Dr. Ted W. Love, Chairman and ... Breakout: http://www.veracast.com/webcasts/bas/37th-annual-2007/id89117822.cfm ...
... Purchase Vehicles, HARRISBURG, Pa., Sept. 5 ... people with disabilities will be,better able to get ... in 27,human service transportation providers. The organizations will ... citizens and people with disabilities deserve the same ...
... of two of Pittsburgh,s,finest long term care providers ... within one health care system. Today, the,Sisters of ... Charity announced,that they will integrate Marian Manor Corporation, ... operated by the Sisters of the Holy Spirit, ...
... N.J., Sept. 6 MedQuist Inc.,(Pink Sheets: ... technology and services, announces the re-launch of ... site has been completely redesigned with,assistance from ... Scott Bennett, MedQuist senior vice president of ...
... in 10 Students Suffer Chronic Back Pain Related ... With two weeks to go until the,annual National ... United States are gearing up to help students,"Pack ... by the American,Occupational Therapy Association (AOTA), is set ...
Cached Medicine News:Health News:Nuvelo Announces Upcoming Conference Calls, Webcasts and Conference Participation 2Health News:Governor Rendell Announces $2.1 Million Investment in Small Transit Vehicles 2Health News:Governor Rendell Announces $2.1 Million Investment in Small Transit Vehicles 3Health News:Area Health Care Providers Announce Plans to Integrate Services 2Health News:MedQuist Re-launches New, Improved Web Site 2Health News:Two Weeks Until National School Backpack Awareness Day 2
(Date:2/27/2015)... Feb. 27, 2015  Boston Scientific Corporation (NYSE: ... Barclays 2015 Annual Healthcare Conference on March 10 in ... Dan Brennan , executive vice president and chief financial ... Relations, will participate in a 25-minute question and answer ... approximately 1:05 p.m. ET. Following a 5-minute break, a ...
(Date:2/27/2015)...  PTC Therapeutics, Inc. (NASDAQ: PTCT ) ... for the fourth quarter and full year ended December ... year for PTC. We are now a growing commercial-stage ... in the rare disease space," stated Stuart W. Peltz, ... proud to bring the first treatment for Duchenne muscular ...
(Date:2/27/2015)... NEWTON, Mass. and JERUSALEM ... privately-held biopharma company developing octreotide capsules, its lead product ... of a $70 million Series E financing round. Participants ... and Sofinnova Ventures, and an undisclosed blue chip public ... F2 Capital, 7 Med Health Ventures, Abingworth and ARCH ...
Breaking Medicine Technology:Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3
... Vical Incorporated (Nasdaq:,VICL) today reported financial results for the ... of 2007 were $3.1 million, compared with,revenues of $7.3 ... loss for,the second quarter of 2007 was $8.2 million, ... $3.2 million, or $0.11 per share, for the second ...
... Vaccine to be tested with ... ImmuneRegen,s ... owned subsidiary of IR BioSciences Holdings, Inc.,(OTC Bulletin Board: IRBO), ... VaxGen Inc. (Pink Sheets: VXGN.PK). As part,of the agreement, ImmuneRegen ...
Cached Medicine Technology:Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 2Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 3Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 4Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 5Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 6ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 2ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 3ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 4
... Bausch & Lomb PreserVision® AREDS formula ... and mineral supplement clinically proven effective in ... Age Related Eye Disease Study (AREDS). , ... and mineral supplement with the antioxidant vitamins ...
Ocuvite® vitamin and mineral supplements contain 2 mg of Lutein 8 times more than the leading multivitamins. Ocuvite also contains vitamin antioxidants A, C and E, as well as the minerals zinc, ...
HydroEye is an exclusive formulation designed to provide dry eye relief and support the body's natural tear formation. Like all ScienceBased Health formulations, it is produced in softgel form for ma...
Easy-to-use desktop QC data management solution...
Medicine Products: